Accepted Manuscript Vascular impairment as a pathological mechanism underlying long-lasting cognitive dysfunction after pediatric traumatic brain injury Ichkova Aleksandra, Beatriz Rodriguez-Grande, Claire Bar, Frederic Villega, Jan Pieter Konsman, Jerome Badaut PII:
S0197-0186(17)30181-X
DOI:
10.1016/j.neuint.2017.03.022
Reference:
NCI 4041
To appear in:
Neurochemistry International
Received Date: 20 November 2016 Revised Date:
29 March 2017
Accepted Date: 31 March 2017
Please cite this article as: Aleksandra, I., Rodriguez-Grande, B., Bar, C., Villega, F., Konsman, J.P., Badaut, J., Vascular impairment as a pathological mechanism underlying long-lasting cognitive dysfunction after pediatric traumatic brain injury, Neurochemistry International (2017), doi: 10.1016/ j.neuint.2017.03.022. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Vascular impairment as a pathological mechanism underlying longlasting cognitive dysfunction after pediatric traumatic brain injury
Aleksandra Ichkova1, Beatriz Rodriguez-Grande1, Claire Bar1,2, Frederic
RI PT
Villega2, Jan Pieter Konsman1 and Jerome Badaut1, 3, 4,§
CNRS UMR 5287, INCIA, University of Bordeaux, France
2
Department of Pediatric Neurology, University Children’s Hospital of
SC
1
Bordeaux, France.
Department of Basic Sciences, Loma Linda University School of Medicine,
§
TE D
Loma Linda, CA, USA
M AN U
3
Corresponding author:
Jerome Badaut, PhD
EP
CNRS UMR 5287, Bordeaux University 146 rue Léo Saignat
AC C
33076 Bordeaux cedex, France E-mail:
[email protected]
1
ACCEPTED MANUSCRIPT Abstract Traumatic brain injury (TBI) is the leading cause of death and disability in children. Indeed, the acute mechanical injury often evolves to a chronic brain disorder with long-term cognitive, emotional and social dysfunction even in the
RI PT
case of mild TBI. Contrary to the commonly held idea that children show better recovery from injuries than adults, pediatric TBI patients actually have worse outcome than adults for the same degree of injury severity. Acute
SC
trauma to the young brain likely interferes with the fine-tuned developmental processes and may give rise to long-lasting consequences on brain’s function.
M AN U
This review will focus on cerebrovascular dysfunction as an important early event TBI that may lead to long-term phenotypic changes in the brain after pediatric TBI. These, in turn may be associated with accelerated brain aging and cognitive dysfunction. Finally, since there no effective treatments are
TE D
currently available, understanding the unique pathophysiological mechanisms
AC C
EP
of pediatric TBI is crucial for the development of new therapeutic options.
2
ACCEPTED MANUSCRIPT Highlights: •
Traumatic brain injury is the leading cause of death and disability among children and young adults Outcome after pediatric TBI is worse than after adult TBI
•
Cerebrovascular dysfunction after pediatric TBI can lead to accelerated
SC
brain aging and cognitive dysfunction
RI PT
•
AC C
EP
TE D
dysfunction, neurovascular unit
M AN U
Keywords: traumatic brain injury, pediatric, development, cerebrovascular
3
ACCEPTED MANUSCRIPT 1. Introduction Traumatic brain injury (TBI) occurs as the consequence of a direct or indirect mechanical force applied to the head. The mechanical force can be a rapid acceleration or deceleration, direct impact or penetration by a projectile,
RI PT
and it is followed by a post-injury altered consciousness with various severities (Maas et al., 2008). The clinical classification of TBI severity is done according to the Glasgow Coma Scale (GCS) for assessment of neurological
SC
function according which the injury can be considered as mild, moderate or severe.
M AN U
TBI is the leading cause of death and disability in pediatrics with infants (<2 years) and adolescents (15-18) being the most commonly affected (Thurman, 2016, Dewan, 2016). Every year around three million pediatric patients worldwide are admitted to hospitals as a result of a TBI (Dewan et al.,
TE D
2016) but this number is likely to be an underestimation as most of the mild TBI cases are not even reported to the health services. However, regardless of whether the injury is mild or not, the initial brain injury can evolve into a
It has been estimated that at least 20% of the pediatric patients
AC C
2015).
EP
chronic brain condition and reduce quality of life of patients (Babikian et al.,
hospitalized after TBI will have lifelong physical disabilities (Thurman, 2016). Even in the absence of physical disabilities, pediatric TBI patients often display cognitive impairments with persistent attention, memory and concentration deficits as well as emotional disorders such as anxiety and depression, which, in turn, greatly influence academic and work performance and cause profound social dysfunction later in life (Babikian et al., 2015; Ryan et al., 2016). It is therefore becoming clear that the costs for rehabilitation,
4
ACCEPTED MANUSCRIPT hospitalization and educational support after pediatric TBI represent important financial burden for the society. Indeed, in the USA alone, around 1 billion dollars per year are charged only for hospital visits of pediatric TBI patients (Schneier et al., 2006).
RI PT
The idea that the developing brain would recover faster and better from an injury driven by the assumption that being “plastic is fantastic” needs to be revised (Giza et al., 2009; Giza and Prins, 2006). In fact, the outcome after
SC
pediatric TBI is even worse compared to adult TBI for the same degree of severity, of the initial injury with more profound edema formation, more severe
M AN U
dysregulation of cerebral blood flow (CBF), higher mortality risk and more behavioral sequelae (Giza and Prins, 2006; Pop and Badaut, 2011). Human brain maturation includes of synaptogenesis, synaptic pruning, myelination, reorganization of neuronal networks, changes in basal CBF and metabolism
TE D
and continues up to the twenties (Giza et al., 2009; Toga et al., 2006). Any injury during the brain maturation has the potential to impact these finely tuned processes with long-lasting consequences on the brain’s function.
EP
However, little is known of the pathophysiological mechanisms underlying the
AC C
long-term consequences of pediatric TBI. As stated above, TBI concerns an external mechanical primary injury,
which results in shear stress being exerted on the brain tissue, which may lead to hemorrhages and cell death, followed by secondary injuries. These latter include metabolic, inflammatory and vascular changes, edema formation and excitotoxicity, all of which have the potential to aggravate outcome, for example through increased cell death. Some of these secondary injuries including reduced cerebral blood flow, impaired cerebral autoregulation (CA),
5
ACCEPTED MANUSCRIPT disruption of the blood brain barrier (BBB) and edema formation are hallmarks of pediatric TBI (Figure 1). These vascular changes have long-lasting consequences and have been suggested as potential mechanisms to explain long-term cognitive and emotional dysfunction (Figure 1; (Jullienne et al.,
RI PT
2016; Jullienne et al., 2014; Keightley et al., 2014; Pop and Badaut, 2011; Pop et al., 2013). Cerebral blood vessels are part of a physiological entity called the neurovascular unit (NVU) which includes glial cells, pericytes and
SC
neurons (Zhang et al., 2012). The present review will address the relationship between vascular function and cognition and will focus on the changes in the
M AN U
NVU after TBI and how its dysfunction can be relevant for the increased vulnerability to long-term cognitive damage after pediatric TBI. We believe that studying TBI-associated changes in the NVU are critical for a better understanding of the mechanisms underlying poor outcome after pediatric
TE D
TBI.
Even though pediatric TBI has a high incidence rate and devastating long-term consequences, there is so far no effective treatment. Moreover, TBI
EP
is receiving relatively limited support in terms of basic research funding
AC C
compared to other brain disorders such as neurodegenerative diseases. This basic research is however required to better understand the pathophysiology of pediatric TBI and develop new treatments.
6
ACCEPTED MANUSCRIPT 2. Developmental aspects after traumatic brain injury: clinical studies 2.1 TBI interferes with ongoing brain maturation and cognitive development Brain development begins very early in prenatal life and continues well into
RI PT
young adulthood with significant structural changes in the gray and the white matter structure. Post-natal brain development starts with growth of short cortico-cortical connections, followed by rapid synaptogenesis and dendritic
SC
development, and finally by myelination and development of local circuitry. Magnetic resonance imaging (MRI), and in particular diffusion tensor imaging
M AN U
(DTI), has provided new insights into of maturation progression within the brain microstructure with a decrease of the overall diffusion of water molecules in the tissue and increase in fractional anisotropy (FA) which may reflect progressive myelination. In fact, increases in FA between structurally
TE D
connected regions have been shown to be correlated with specific skill acquisition throughout childhood and adolescence, including reading performance, visuospatial abilities, language response inhibition, and
EP
memory. The corpus callosum and visual nerve tracts reach the earliest
AC C
plateau of FA during brain development compared to “cortical-associativetracts” that are supposed to underlie the most complex executive and attention functions (Jernigan et al., 2011; Lebel et al., 2008). This maturation process is genetically programmed, but also very sensitive to environmental stimuli and experience through dynamic modifications of structural and functional neuronal networks. While this neuroplasticity is considered beneficial in healthy development, recent research work indicates that children aged <5 years are highly vulnerable to long-term deficits after TBI
7
ACCEPTED MANUSCRIPT (Anderson et al., 2011). In general, pediatric TBI is frequently associated with poor outcomes including impairment of processing speed, attention, memory and executive functions with a direct relationship between the severity of the injury and the importance of the deficits (Anderson et al., 2013; Babikian and
RI PT
Asarnow, 2009; Garcia et al., 2015). Furthermore, age at the time of the injury is relevant to the severity of lasting dysfunctions. In fact, traumatic injuries early in brain development have worse outcomes than later ones because TBI
SC
disrupts recently established skills and also potentially interferes with the course of acquisition and consolidation of later skills (Anderson et al., 2005;
M AN U
Catroppa et al., 2008). Therefore, neuroplasticity may turn into vulnerability depending on injury-related factors and environmental influences during certain critical periods of brain development (Anderson et al., 2011). The acute injury processes after TBI may give rise to chronic disease
TE D
symptoms with cognitive deficits emerging several years post-insult (Anderson et al., 2012; Babikian et al., 2015). For example, 10 years after mild to severe TBI, children exhibit impairment in intellectual abilities,
EP
particularly in processing speed, leading to long-term consequences on
AC C
school performance (Anderson et al., 2012). Moreover, when the level of exigency increases with later grades in school and requires more complex and efficient cognitive processing abilities, the gap between these children and their healthy counterparts appears more evident (Babikian et al., 2015; Chevignard et al., 2016; Ryan et al., 2015; Ryan et al., 2016). In contrast, TBI in adulthood mostly affects the learning repertoire and acquisition of new knowledge at long-term.
8
ACCEPTED MANUSCRIPT 2.2 Cerebrovascular function and cognition Brain activity is highly dependent on adequate blood supply and even a short interruption of blood flow can lead to irreversible cellular damage. Vascular dysfunction and neuronal damage are associated with cognitive
RI PT
impairments in many neurodegenerative diseases as well as in healthy aging (Iadecola, 2004; Raz et al., 2016). Cerebrovascular dysfunction is a landmark of the secondary injuries in pediatric TBI and the resulting changes in blood
SC
supply may have direct consequences for neuronal functioning (Jullienne et al., 2016; Pop and Badaut, 2011). Decreased CBF after TBI can prompt
M AN U
neuronal death and damage by not meeting the metabolic demands of neuronal activity. Moreover, edema formation and changes in BBB permeability can disturb the brain homeostasis and contribute to neuronal dysfunction with a cascade of secondary injury events including excitoxicity
TE D
(glutamate release and resulting higher metabolic demand). Disruption of the microvasculature and the BBB together with neuronal injury have recently been proposed as pathological mechanisms for cognitive dysfunction after
EP
TBI (Wang and Li, 2016).
AC C
Various clinical studies have shown a significant alteration of the vascular reactivity during the acute period after pediatric TBI (see below). Interestingly, studies employing transcranial doppler (TCD) ultrasonography have shown that major hyperemia but also hypoperfusion are positively correlated to poorer cognitive outcomes in children with Sickle cells disease and preterm infants, respectively (Bakker et al., 2014). Similarly, bloodoxygen level-dependent (BOLD) functional MRI studies point to some vascular alterations in pediatric populations that are at risk of cognitive
9
ACCEPTED MANUSCRIPT impairments, such as preterm infants or children already presenting cognitive impairments like autistic children (Taylor et al., 2013). There is some evidence from adult TBI clinical studies that cognitive dysfunction could be associated with vascular modifications. For example, chronic traumatic encephalopathy
as
dementia
and
cognitive
impairments,
is
RI PT
(CTE), a disease associated with repetitive brain trauma with symptoms such characterized
by
hyperphosphorylated tau deposits mainly around the small vessels in the
SC
cortex (McKee et al., 2015). Moreover, it seems that treatments for adult TBI that improve cerebral perfusion and decrease the intracranial pressure such
M AN U
as hypothermia lead to improved cognitive outcome (Adelson et al., 2005). All together, these clinical data support the hypothesis that cerebrovascular impairment is associated with poor cognitive outcome. Similarly, the link between cerebrovascular dysfunction and cognitive dysfunction is also more
accepted
for
several
brain
disorders
including
TE D
becoming
neurodegenerative diseases such as Alzheimer disease. Indeed, reduced CBF and breakdown of the BBB likely precede cognitive impairments in
EP
Alzheimer’s disease (Bell and Zlokovic, 2009). Similarly, the long-term
AC C
cognitive impairments after early life TBI may represent consequences of vascular dysfunction and ensuing gray and white matter damage (Figure 1, (Jullienne et al., 2016; Keightley et al., 2014; Pop and Badaut, 2011).
10
ACCEPTED MANUSCRIPT 3. Cerebrovascular physiology in healthy children and development of the BBB 3.1 Cerebral blood flow and autoregulation Referent values for CBF and limits of autoregulation obtained in healthy
RI PT
children are scarce. One of the ways to measure cerebral blood flow velocity (CBFV) is by using noninvasive TCD ultrasonography. These measurements show that CBFV increases with age, peaks at 6-9 years old and decreases
SC
after 10 years (Udomphorn et al., 2008). Similarly, MRI arterial spin labeling (ASL) demonstrated that CBF values are highest in children aged 4-12 (97+/-
M AN U
5 mL/100 g/minute in gray matter and 26+/-1 mL/100 g/minute in white matter) to drop in adolescence (age 13-19) until they reach adult values (gray matter 58+/-4 mL/100 g/minute, white matter 20+/-1 mL/100 g/minute) around the twenties (Biagi et al., 2007). The higher CBF values in childhood are likely
TE D
related to the higher metabolic demand of the developing brain. Cerebral vasoreactivity (CVR) is the capacity of the brain vasculature to respond by vasodilation to brain activity and can be assessed by inducing
EP
changes in blood CO2. CVR values are also higher in children compared to
AC C
adults (Philip et al., 2009). A recent study with healthy subjects aged 9-30 used blood-oxygen level-dependent (BOLD) magnetic resonance imaging (MRI) to assess changes in CVR in response to computer-controlled CO2 stimuli (Leung et al., 2016). The results of this study show that CVR increases with age in both gray and white matter until the age of 14.7 years and then decreases with age (Leung et al., 2016). Cerebral autoregulation (CA) is a crucial physiological principle by which the cerebral blood vessels dilate and constrict to maintain CBF constant under
11
ACCEPTED MANUSCRIPT a range of cerebral perfusion pressure (CPP) values of 50 to 150 mm Hg. Outside of this range CBF is significantly impaired; low CPP values lead to hypoperfusion and ischemia, while high CPP values contribute to hyperemia. The few studies that have investigated cerebral autoregulation in healthy
RI PT
children (6 months – 14 years) report no differences in the lower limit of CA among the different ages and when compared to adult values (Vavilala et al., 2003). However, a study comparing autoregulatory capacity between healthy
SC
adults and adolescents has found that the autoregulatory index, that describes how fast the blood flow velocity returns to baseline levels after
M AN U
transiently decreasing the mean arterial pressure (MAP), is lower in adolescents (age 12-17) when compared to adults (Vavilala, 2002). Altogether, the findings indicate that properties of the brain vasculature may
TE D
differ between children and adults during brain development.
3.2 BBB and brain development
The maintenance of BBB properties is important for brain homeostasis and
EP
neuronal functioning. At the level of the endothelial cells the BBB can be
AC C
subdivided into three elemental features (Abbott et al., 2006): 1) the “physical barrier”, formed by junctional complexes of tight junction proteins (e.g. occludin, claudin-5 and zona occludens-1) between endothelial cells that prevent paracellular diffusion, thus “forcing” most substances to face the endothelial cell barrier; 2) the “transport barrier”, composed by specific transport proteins in endothelial cells that control the crossing of nutrients, ions and toxins between the blood stream and brain (Abbott et al., 2010; Abbott et al., 2006); 3) the “metabolic barrier” formed by a combination of
12
ACCEPTED MANUSCRIPT intracellular and extracellular enzymes that inactivate molecules capable of penetrating cerebral endothelial cells. It is important, however, to point out that certain solutes of large molecular weight are able to cross the “physically intact” BBB by transcytosis, that is they are internalized by vesicular caveolae
RI PT
on one side of the endothelial cell, routed across the cytoplasm and finally exocytosed at the opposite site (for review De Bock et al., 2016). These structural and functional aspects of the BBB are remarkably conserved among
SC
species (Bundgaard and Abbott, 2008; Cserr and Bundgaard, 1984).
Maturation of the BBB starts soon after angiogenesis. Physical and
M AN U
transport barrier phenotypes are observed as early as embryonic day (E) 12 in rodents, when tight junction proteins and some influx transporters start to be expressed (Daneman et al, 2010). An important concept is that the BBB does not “switch” to a tight barrier at a specific time during angiogenesis.
TE D
Instead, the tightness of the barrier gradually increases in a region-dependent manner while angiogenesis is progressing (Robertson et al., 1985). Interestingly, pericyte recruitment to the CNS correlates temporally with
EP
maturation of BBB (Daneman et al., 2010; Winkler et al., 2010, 2011).
AC C
Endothelial cells later become covered with astrocytic end-feet that will contribute to the final maturation of the BBB and induce increased tight junction protein and specific transporter expression (Abbott et al., 2006). Paracellular diffusion diminishes during these latter stages of endothelial cellastrocytic end-feet complex formation and basement membrane development as part of perivascular maturation process. In parallel, the levels of certain transporters, e.g., monocarboxylate transporters (MCT), decline with cerebral maturity in brain and vasculature of humans and rodents (Abbott et al., 2006).
13
ACCEPTED MANUSCRIPT Hormones are also important regulators of barrier maturation (Stonestreet et al., 2000). Interestingly, during the perinatal period increases in endogenous corticosteroids serve to protect the fetal and neonatal brain by reducing its own permeability (Stonestreet et al., 2000; Sysyn et al., 2001). However, in a
RI PT
more mature brain, increased glucocorticoids can result in increased BBB permeability (Stonestreet et al., 2000; Sysyn et al., 2001). Moreover, the BBB in the developing brain shows higher inward transport of glucose and amino
SC
acids, as well as different expression of some efflux transporters and signaling pathways (Daneman et al., 2010; Saunders et al., 2012) compared to adults
M AN U
indicating functional differences between the BBB in the developing and the adult brain. Therefore, it is critical to bear in mind that the vascular response to injury changes depending on developmental stage (Fernández-López et al., 2012). It was shown that the BBB is more vulnerable to damage in response
TE D
to hypoxic-ischemic insult in younger (post-natal day 7) compared to older (post-natal day 21) rat pups (Muramatsu et al., 1997). Furthermore, the BBB transporter activity differed between juvenile post-natal day 21 and adult rats
EP
under neuroinflammatory conditions (Harati et al., 2012).
AC C
Since BBB disruption is a major cause of mortality and long-term neurological deficits in moderate to severe TBI adult patients (Shlosberg et al., 2010) and is also present early after mild-TBI (Readnower et al., 2010), there is a need to study BBB changes in pediatric TBI at early and long term.
14
ACCEPTED MANUSCRIPT 4. Cerebrovascular dysfunction after pediatric TBI 4.1 Cerebral blood flow and autoregulation Cerebrovascular dysfunction is an important hallmark of TBI and can be associated with accelerated brain aging and cognitive dysfunction (Jullienne
RI PT
et al., 2016). Contrary to the adult brain, the intensive metabolic, cellular and vascular changes render the young brain more sensitive to changes in blood supply (Obermeier et al., 2013; Toga et al., 2006). In accordance with this
SC
idea, an important mismatch between the metabolic demand and blood supply has been reported after pediatric TBI. Pediatric patients exhibit more profound
M AN U
reductions in CBF after TBI than adults (for review Pop and Badaut, 2011). The decrease of CBF puts the brain at risk of ischemia, which is a significant predictor of poor outcome after pediatric TBI (Adelson et al., 2011; Philip et al., 2009).
TE D
Cerebral autoregulation (CA) is also impaired after TBI and negatively influences long-term outcome. In fact, impaired CA has been associated with unfavorable outcome up to 12 months post TBI (Nagel et al.,
EP
2016; Vavilala et al., 2006; Vavilala et al., 2008) with younger age at the time
AC C
of injury being a risk factor for impaired CA (Freeman et al., 2008). Clinical studies have demonstrated impaired cerebral autoregulation in around 40% of children with moderate and severe TBI and in 17% of children with mild TBI (Vavilala et al., 2004; Vavilala et al., 2008). The loss of CA means that the regulation of CBF becomes dependent on the CPP with a low CPP resulting in low CBF thus exposing the brain to ischemia and ensuing secondary injuries. Additionally, CO2 vasoreactivty is also impaired after pediatric TBI such that changes of less than 2% are associated with poor outcome
15
ACCEPTED MANUSCRIPT comparable to that observed after impairment of CA (Adelson et al., 1997; Maa et al., 2016). Reductions of CBF, impaired cerebrovascular reactivity and CA have been reported in various experimental pediatric TBI models. Decreased
RI PT
CBF and greater constrictions in pial arteries have been observed in an experimental TBI model in the pig with greater CBF and pial arteries diameter reductions occurring in the newborn (1-5 days old) compared to the juvenile
SC
pigs (3-4 weeks old) (Armstead and Kurth, 1994). The 1-5 days old pigs correspond to newborn to infant in human age and the juvenile pigs to a child
M AN U
5-8 years of age. Moreover, CA was also impaired in this model and again with greater extent in the newborn compared to the juvenile pig (Armstead, 1999b). Interestingly, the CBF reductions and impaired CA could be a result of increased endothelin (ET)-1 production and secretion, as high ET-1 levels
TE D
have been observed in the cerebrospinal fluid (CSF) in both animal studies using pediatric TBI models (Armstead, 1999a; Armstead and Kreipke, 2011) and in clinical pediatric studies (Salonia et al., 2010). Moreover, the increase
EP
in CSF ET-1 was of greater magnitude and duration in the newborn compared
AC C
to the juvenile pig, which can explain the greater impairment of the CA in the newborn pigs (Armstead, 1999). In accordance with these data, pre-treatment with an ET-1 antagonist partially restored the impaired CA response after TBI in the newborn and juvenile pigs and attenuated decreased CBF (Armstead, 1999a; Armstead and Raghupathi, 2011). In an experimental study using rat TBI model to compare the outcome between juvenile (post-natal day 17), preadolescent rats (post-natal day 28) and adult rats, more prolonged hypotension has been observed in the developing brain compared to the adult
16
ACCEPTED MANUSCRIPT brain, which may have contributed to the increased mortality during development (Prins et al., 1996). The cerebral vasodilation to N-methyl-Daspartate receptor agonist (NMDA) in pial arteries is reversed to vasoconstriction after TBI in newborn and juvenile piglets and again with
RI PT
greater extent in the newborn (Armstead, 2004; Armstead et al., 2011a). The activation of the intracellular signaling involving the c-Jun N-terminal kinase (JNK) contributes to this impaired response (Armstead et al., 2011b).
SC
Interestingly, inhibition of the JNK pathway increases CBF and improves behavioral outcome in a post-natal day 17-rat model of TBI (personal
M AN U
communication, unpublished data). These findings point to both ET-1 and JNK as a potential therapeutic targets in pediatric TBI. Taken together, both clinical and experimental studies show important changes in CBF, CA and vascular reactivity after pediatric TBI that might be associated with poor
4.2 Edema
TE D
outcome on the long-term.
EP
One consequence of trauma-associated damage is edema formation.
AC C
Children develop diffuse edema more often and earlier after TBI compared to adults (Aldrich et al., 1992; Bauer and Fritz, 2004; Lang et al., 1994). This difference with the adult can be due to weaker cervical support combined with higher water content, relatively larger heads and softer skulls in younger children, which alter the biomechanics of the injury and can lead to a different type of damage, even with the same TBI parameters (Ommaya et al., 2002). Mortality in children with diffuse edema is more than twice as frequent as in children without it (Aldrich et al., 1992) and, for survivors, edema formation
17
ACCEPTED MANUSCRIPT correlates with poorer long-term outcome (Feickert et al., 1999). Animal studies have shown that, within the juvenile population, post-natal day 21 mice have more edema and for a longer time than post-natal day 24 mice (Rossi, 2015). Altogether these data suggest that younger children may be
RI PT
more vulnerable to TBI than adult, in large part due to more important edema formation.
Edema formation occurs first at a cellular level, involving cell swelling
SC
due to ionic imbalance and osmotic gradients, and then at a vascular level, involving BBB dysfunctions (Jullienne et al., 2016; Unterberg et al., 2004). In
M AN U
addition to the post-TBI changes in transcytosis and tight junction expression discussed above, water channels are also key elements in edema formation. The expression of the water channel aquaporin 4 (AQP4), present in astrocyte end-feet, is increased 3 days after TBI in post-natal day 17 rats and
TE D
contributes to the peak of edema formation (Fukuda et al., 2013; Fukuda et al., 2012). Later on, AQP4 also seems to be involved in edema resolution, however this has not yet been studied in detail in models of pediatric TBI
AC C
EP
(Badaut et al., 2014).
4.3 Blood brain barrier and perivascular changes Changes in the NVU, including BBB dysfunction as a result of a
physical “opening/leakage” of the barrier have been described during the first week after injury both in adult and pediatric TBI. The mechanisms behind the “opening/leakage” of BBB are still part of active research. At early time-points after experimental pediatric TBI, BBB opening can be visualized with stains like Evans blue or immunoglobulin G (IgG) detection
18
ACCEPTED MANUSCRIPT post mortem (Badaut et al., 2015). In pediatric TBI models the BBB “opening/leakage” occurs within the first day after injury as shown by the presence of the MRI contrast agent gadolinium. This contributes to vasogenic edema formation, which may underlie increased contrast in T2-weighted MRI
RI PT
(Beaumont et al., 2006; Fukuda et al., 2012). In this case, it is associated with a decrease of claudin-5 expression, a protein involved in tight junction formation (Badaut et al., 2015).
SC
However, BBB “leakage” can occur early on without a “physical rupture” of the BBB or changes in claudin-5 expression. Instead, changes in
M AN U
the rate of caveolin-1-mediated trancytosis may play a role in this early BBB permeability, as shown in an adult experimental stroke model (Knowland et al., 2014). Experimental studies have shown that caveolin-1 is also involved in the stabilization of the tight junction proteins such as claudin-5 within the lipid
TE D
raft domain and of the efflux pump P-glycoprotein (P-gp) (Jodoin et al., 2003; McCaffrey et al., 2007; McCaffrey et al., 2012). P-gp is an endothelial efflux pump known to expel several proteins from endothelial cells to the
EP
extracellular space, mostly into the blood compartment. In post-natal day 17
AC C
rats, a bi-phasic increase of caveolin-1 expression in the endothelial cells at 1 and 7 days post TBI suggests that the early increase may contribute to increased transcytosis and the second to the stabilization of tight junction proteins and P-gp (Badaut et al., 2015). Until now, the exact role of caveolin-1 in brain injury and especially in pediatric TBI is still unclear (Badaut et al., 2015). Monocarboxylate transporters (MCTs), which are expressed on the endothelial cells membrane, are affected after TBI. MCT expression in the
19
ACCEPTED MANUSCRIPT brain and the vasculature declines with normal cerebral maturation in humans and rodents (Abbott et al., 2006). However, MCT levels in brain lysates are increased during the first 24 hours after controlled cortical impact (CCI) in adolescent post-natal day 35 rats and post-natal day 75 rats (Prins and Giza,
RI PT
2006). Sham post-natal day 35 rats had higher baseline MCT levels than adult sham rats but both age groups had a 26-28% increase of MCT expression at 6 hours after injury and 16% increase at 24 hours after injury. MCTs are
SC
known to facilitate the transport of the ketone bodies (Pierre and Pellerin, 2005). In a comparable study, the potential benefit of ketogenic diet on TBI
M AN U
outcome has been tested. However, only post-natal day 35 rats had improvements in motor function and cognition and showed preserved cortical tissue after consuming a ketogenic diet that increased MCT levels after injury, whereas no therapeutic effect of the diet was observed in post-natal day 75
TE D
rats (Appelberg et al., 2009). This overall improvement after ketogenic diet has been recently explained by the improvement of the mitochondrial respiratory complex activity after injury in post-natal day 35 rats (Greco et al.,
EP
2016). Interestingly, clinical studies have demonstrated that intravenous
AC C
injection of hypertonic lactate is beneficial in recovery after TBI in adults (Bouzat et al., 2014; Quintard et al., 2016). In our studies, we showed that despite the return to normal T2 values
and the absence of IgG extravasation at 7 days after TBI in post-natal day 17 rats, long-term phenotypic changes occurred in the brain endothelium (Pop et al., 2013). These changes were associated with a sustained increase of caveolin-1 and claudin-5 expressions and decreased P-gp expression (Figure 2, 3) up to 2 months after injury (Badaut and Bix, 2014; Pop et al., 2013). As
20
ACCEPTED MANUSCRIPT discussed above, changes in claudin-5 and P-gp expression could be due to the alteration of the stability of these proteins by the modification of caveolin-1 expression in endothelial cells (Badaut et al., 2015). P-gp has been proposed by several research groups to be implicated in amyloid-beta (Aβ) clearance
RI PT
from the brain tissue into the blood circulation (Cirrito et al., 2005). Interestingly, decreased levels of P-gp occur in parallel with Aβ accumulation in the brain 2 and 6 months after injury in our experimental model of pediatric
SC
TBI (Jullienne et al., 2014; Pop et al., 2013). We observed persistent behavioral and motor deficits up to 6 months post injury, primarily in spatial
M AN U
memory measured with Morris water maze (Kamper et al., 2013). The phenotypic changes in the brain endothelial cells were found to be associated with a decrease of capillary diameter (Figure 2) and structural changes in the perivascular matrix with an increase of perlecan and fibronectin expression at
TE D
2 and 6 months post injury (Figure 2) (Jullienne et al., 2014). Both perlecan and fibronectin have been shown to be implicated in impaired drainage of Aβ (Figure 3, (Hawkes et al., 2013; Hawkes et al., 2014) by accelerating its
EP
aggregation and providing a higher stability of Aβ in the basement membrane
AC C
(Castillo et al., 1997; Cotman et al., 2000). Altogether, these long-term vascular changes may contribute to decreased Aβ clearance and result in its accumulation of Aβ (Figure 3) due to a decrease of its clearance and in a way similar to what has been proposed to occur in Alzheimer’s disease (Jullienne et al., 2014; Pop et al., 2013). These new insights into the long-term pathophysiology of TBI may give rise to new therapeutical targets beyond the acute period in pediatric TBI patients.
21
ACCEPTED MANUSCRIPT 5. Treatments Hypothermia, hyperosmolar therapy and a wide range of antiinflammatory drugs have been tested with more or less success in adult TBI after having shown beneficial effects in animal models, and most of the
RI PT
current studies that explore the mechanisms of action of these therapies are carried out in experimental models of adult TBI. However, very few therapies have actually been evaluated in pediatric TBI whether in experimental studies
SC
or in the clinic. Given the different characteristics of the developing brain, it is
compared to adulthood.
M AN U
likely that those same treatments would have different effects in early life
Since high intracranial pressure and edema are common complications after pediatric TBI, several therapies targeting these have been tested in experimental models. Hypothermia has been known for a long time to reduce
TE D
edema after TBI (Jiang et al., 1992). A recent study has shown that pharmacological hypothermia, which can be achieved by targeting specific receptors or channels involved in thermoregulation, can reduce brain damage
EP
and improve behavior also in post-natal 14 rats (Gu et al., 2015).
The
AC C
beneficial effect of hypothermia is thought to occur partly through a reduction of inflammation, metabolic rate and excitotoxicity (Sahuquillo and Vilalta, 2007). However, the efficacy of hypothermia in pediatric TBI remains unclear with some conflicting results among clinical studies (Zhang et al., 2015). In clinical practice, neuroprotective strategies after pediatric TBI concern essentially in monitoring of intracranial pressure to sustain CPP using hyperosmolar therapy, CSF drainage and decompressive craniotomy (Kochanek et al., 2012). While hyperosmolar therapy has moderate benefits
22
ACCEPTED MANUSCRIPT (Roumeliotis et al., 2016), decompressive surgery improves outcome in survivors of severe pediatric TBI, even though it does not directly reduce edema (Figaji et al., 2003; Mhanna et al., 2015). On a molecular level, studies targeting water channels and molecular
RI PT
pathways linked to vascular dysfunction have been evaluated in juvenile animals. After TBI in post-natal day 17 rats, silencing of AQP4 reduced edema and improved motor and cognitive function (Fukuda et al., 2013) while
SC
inhibition of the JNK pathway increased CBF and improved behavioral outcome (personal communication, unpublished data). Moreover, the
M AN U
combination of these strategies (inhibition of JNK and silencing of AQP4) has been shown to have synergistic effects at early, but not at later, time-points (Ajao et al., 2011; Ajao et al., 2012; Fukuda et al., 2013; Margulies et al., 2016). Reduction of post-TBI vasoconstriction using an inhibitor/antagonist of
TE D
ET-1 production/action has also given good results in neonatal and juvenile piglets as it resulted in less neurodegeneration (Kasemsri and Armstead, 1997).
EP
Anti-inflammatory treatments, progesterone or implantation of iPSC-
AC C
derived neural progenitor cells have also been tested in different experimental models of pediatric TBI with most of them leading to improved outcome (Hanlon et al., 2016; Mannix et al., 2014; Robertson and Saraswati, 2015; Wei et al., 2016), however their impact on the vasculature has not been evaluated.
6. Conclusions In this review, we focused on the vascular dysfunction after pediatric TBI. From the clinical data, our experiments and those of others, we believe
23
ACCEPTED MANUSCRIPT that the vascular dysfunction observed just after primary injury continues for several months and years. In addition to the primary neuronal damages, the vascular dysfunction is very likely one of the mechanisms contributing to the
RI PT
long-term cognitive dysfunction.
SC
Acknowledgements:
The authors wish to acknowledge the following funding: Fondation des
M AN U
gueules cassées (JB), eraNET neuron CNSaflame (JB), ANR-TRAIL (JB) and CNRS support.
TE D
References:
Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R., Begley, D.J.,
25.
EP
2010. Structure and function of the blood-brain barrier. Neurobiol Dis 37, 13-
AC C
Abbott, N.J., Ronnback, L., Hansson, E., 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53. Adelson, P.D., Clyde, B., Kochanek, P.M., Wisniewski, S.R., Marion, D.W., Yonas, H., 1997. Cerebrovascular response in infants and young children following severe traumatic brain injury: a preliminary report. Pediatr Neurosurg 26, 200-207. Adelson, P.D., Ragheb, J., Kanev, P., Brockmeyer, D., Beers, S.R., Brown, S.D., Cassidy, L.D., Chang, Y., Levin, H., 2005. Phase II clinical trial of
24
ACCEPTED MANUSCRIPT moderate hypothermia after severe traumatic brain injury in children. Neurosurgery 56, 740-754; discussion 740-754. Adelson, P.D., Srinivas, R., Chang, Y., Bell, M., Kochanek, P.M., 2011. Cerebrovascular response in children following severe traumatic brain injury.
RI PT
Childs Nerv Syst 27, 1465-1476.
Ajao, D., Kamper, J., Fukuda, A.M., Pop, V., Sorensen, D.W., Toca, V.B., Hartman, R.E., Obenaus, A., Ashwal, S., Badaut, J., 2011. Inhibition of the
SC
JNK pathway improves long-term neurobehavioral outcomes after juvenile traumatic brain injury. Society for Neuroscience Abstract Viewer and Itinerary
M AN U
Planner 41.
Ajao, D.O., Pop, V., Kamper, J.E., Adami, A., Rudobeck, E., Huang, L., Vlkolinsky, R., Hartman, R.E., Ashwal, S., Obenaus, A., Badaut, J., 2012. Traumatic brain injury in young rats leads to progressive behavioral deficits
2060-2074.
TE D
coincident with altered tissue properties in adulthood. J Neurotrauma 29,
Aldrich, E.F., Eisenberg, H.M., Saydjari, C., Luerssen, T.G., Foulkes, M.A.,
EP
Jane, J.A., Marshall, L.F., Marmarou, A., Young, H.F., 1992. Diffuse brain
AC C
swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 76, 450-454. Anderson, V., Beauchamp, M.H., Yeates, K.O., Crossley, L., Hearps, S.J., Catroppa, C., 2013. Social competence at 6 months following childhood traumatic brain injury. J Int Neuropsychol Soc 19, 539-550. Anderson, V., Godfrey, C., Rosenfeld, J.V., Catroppa, C., 2012. 10 years outcome from childhood traumatic brain injury. Int J Dev Neurosci 30, 217224.
25
ACCEPTED MANUSCRIPT Anderson, V., Spencer-Smith, M., Wood, A., 2011. Do children really recover better? Neurobehavioural plasticity after early brain insult. Brain 134, 21972221. Anderson, V.A., Catroppa, C., Haritou, F., Morse, S., Rosenfeld, J.V., 2005.
RI PT
Identifying factors contributing to child and family outcome 30 months after traumatic brain injury in children. J Neurol Neurosurg Psychiatry 76, 401-408. Appelberg, K.S., Hovda, D.A., Prins, M.L., 2009. The effects of a ketogenic
SC
diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. J Neurotrauma 26, 497-506.
M AN U
Armstead, W.M., 1999a. Age-dependent impairment of K(ATP) channel function following brain injury. J Neurotrauma 16, 391-402. Armstead, W.M., 1999b. Cerebral hemodynamics after traumatic brain injury of immature brain. Exp Toxicol Pathol 51, 137-142.
TE D
Armstead, W.M., 2004. NMDA and age dependent cerebral hemodynamics after traumatic brain injury. Exp Toxicol Pathol 56, 75-81. Armstead, W.M., Kiessling, J.W., Cines, D.B., Higazi, A.A., 2011a. Glucagon
EP
protects against impaired NMDA-mediated cerebrovasodilation and cerebral
AC C
autoregulation during hypotension after brain injury by activating cAMP protein kinase A and inhibiting upregulation of tPA. J Neurotrauma 28, 451457.
Armstead, W.M., Kiessling, J.W., Riley, J., Cines, D.B., Higazi, A.A., 2011b. tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK. Neurol Res 33, 726-733.
26
ACCEPTED MANUSCRIPT Armstead, W.M., Kreipke, C.W., 2011. Endothelin-1 is upregulated after traumatic brain injury: a cross-species, cross-model analysis. Neurol Res 33, 133-136. Armstead, W.M., Kurth, C.D., 1994. Different cerebral hemodynamic
RI PT
responses following fluid percussion brain injury in the newborn and juvenile pig. J Neurotrauma 11, 487-497.
Armstead, W.M., Raghupathi, R., 2011. Endothelin and the neurovascular unit
SC
in pediatric traumatic brain injury. Neurol Res 33, 127-132.
Babikian, T., Asarnow, R., 2009. Neurocognitive outcomes and recovery after
296.
M AN U
pediatric TBI: meta-analytic review of the literature. Neuropsychology 23, 283-
Babikian, T., Merkley, T., Savage, R.C., Giza, C.C., Levin, H., 2015. Chronic Aspects of Pediatric Traumatic Brain Injury: Review of the Literature. J
TE D
Neurotrauma 32, 1849-1860.
Badaut, J., Ajao, D.O., Sorensen, D.W., Fukuda, A.M., Pellerin, L., 2015. Caveolin expression changes in the neurovascular unit after juvenile traumatic
J.,
Bix,
G.J.,
2014.
Vascular
neural
network
phenotypic
AC C
Badaut,
EP
brain injury: Signs of blood-brain barrier healing? Neuroscience 285, 215-226.
transformation after traumatic injury: potential role in long-term sequelae. Transl Stroke Res 5, 394-406. Badaut, J., Fukuda, A.M., Jullienne, A., Petry, K.G., 2014. Aquaporin and brain diseases. Biochim Biophys Acta 1840, 1554-1565. Bakker, M.J., Hofmann, J., Churches, O.F., Badcock, N.A., Kohler, M., Keage, H.A., 2014. Cerebrovascular function and cognition in childhood: a systematic review of transcranial Doppler studies. BMC Neurol 14, 43.
27
ACCEPTED MANUSCRIPT Bauer, R., Fritz, H., 2004. Pathophysiology of traumatic injury in the developing brain: an introduction and short update. Exp Toxicol Pathol 56, 6573. Beaumont, A., Fatouros, P., Gennarelli, T., Corwin, F., Marmarou, A., 2006.
RI PT
Bolus tracer delivery measured by MRI confirms edema without blood-brain barrier permeability in diffuse traumatic brain injury. Acta Neurochir Suppl 96, 171-174.
SC
Bell, R.D., Zlokovic, B.V., 2009. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118, 103-113.
M AN U
Biagi, L., Abbruzzese, A., Bianchi, M.C., Alsop, D.C., Del Guerra, A., Tosetti, M., 2007. Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging 25, 696702.
TE D
Bouzat, P., Sala, N., Suys, T., Zerlauth, J.B., Marques-Vidal, P., Feihl, F., Bloch, J., Messerer, M., Levivier, M., Meuli, R., Magistretti, P.J., Oddo, M., 2014. Cerebral metabolic effects of exogenous lactate supplementation on the
EP
injured human brain. Intensive Care Med 40, 412-421.
AC C
Bundgaard, M., Abbott, N.J., 2008. All vertebrates started out with a glial blood-brain barrier 4-500 million years ago. Glia 56, 699-708. Castillo, G.M., Ngo, C., Cummings, J., Wight, T.N., Snow, A.D., 1997. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem 69, 2452-2465.
28
ACCEPTED MANUSCRIPT Catroppa, C., Anderson, V.A., Morse, S.A., Haritou, F., Rosenfeld, J.V., 2008. Outcome and predictors of functional recovery 5 years following pediatric traumatic brain injury (TBI). J Pediatr Psychol 33, 707-718. Chevignard, M., Francillette, L., Toure, H., Brugel, D., Meyer, P., Vannier,
RI PT
A.L., Opatowski, M., Watier, L., 2016. Academic outcome, participation and health-related quality of life following childhood severe traumatic brain injury: Results of a prospective longitudinal study: The seven-year follow-up of the
SC
TGE cohort. Ann Phys Rehabil Med 59S, e133.
Cirrito, J.R., Deane, R., Fagan, A.M., Spinner, M.L., Parsadanian, M., Finn,
M AN U
M.B., Jiang, H., Prior, J.L., Sagare, A., Bales, K.R., Paul, S.M., Zlokovic, B.V., Piwnica-Worms, D., Holtzman, D.M., 2005. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115, 3285-3290.
TE D
Cotman, S.L., Halfter, W., Cole, G.J., 2000. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci 15, 183-198.
EP
Cserr, H.F., Bundgaard, M., 1984. Blood-brain interfaces in vertebrates: a
AC C
comparative approach. Am J Physiol 246, R277-288. Daneman, R., Zhou, L., Kebede, A.A., Barres, B.A., 2010. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566.
De Bock, M., Van Haver, V., Vandenbroucke, R.E., Decrock, E., Wang, N., Leybaert, L., 2016. Into rather unexplored terrain-transcellular transport across the blood-brain barrier. Glia 64, 1097-1123.
29
ACCEPTED MANUSCRIPT Dewan, M.C., Mummareddy, N., Wellons, J.C., Bonfield, C.M., 2016. Epidemiology of Global Pediatric Traumatic Brain Injury: Qualitative Review. World Neurosurg 91, 497-509.e491.
impact of risk factors on outcome. J Trauma 47, 33-38.
RI PT
Feickert, H.J., Drommer, S., Heyer, R., 1999. Severe head injury in children:
Fernández-López, D., Faustino, J., Daneman, R., Zhou, L., Lee, S.Y., Derugin, N., Wendland, M.F., Vexler, Z.S., 2012. Blood-brain barrier
the rat. J Neurosci 32, 9588-9600.
SC
permeability is increased after acute adult stroke but not neonatal stroke in
M AN U
Figaji, A.A., Fieggen, A.G., Peter, J.C., 2003. Early decompressive craniotomy in children with severe traumatic brain injury. Childs Nerv Syst 19, 666-673.
Freeman, S.S., Udomphorn, Y., Armstead, W.M., Fisk, D.M., Vavilala, M.S.,
TE D
2008. Young age as a risk factor for impaired cerebral autoregulation after moderate to severe pediatric traumatic brain injury. Anesthesiology 108, 588595.
EP
Fukuda, A.M., Adami, A., Pop, V., Bellone, J.A., Coats, J.S., Hartman, R.E.,
AC C
Ashwal, S., Obenaus, A., Badaut, J., 2013. Posttraumatic reduction of edema with aquaporin-4 RNA interference improves acute and chronic functional recovery. J Cereb Blood Flow Metab. Fukuda, A.M., Pop, V., Spagnoli, D., Ashwal, S., Obenaus, A., Badaut, J., 2012. Delayed increase of astrocytic aquaporin 4 after juvenile traumatic brain injury: Possible role in edema resolution? Neuroscience 222, 366-378.
30
ACCEPTED MANUSCRIPT Garcia, D., Hungerford, G.M., Bagner, D.M., 2015. Topical review: negative behavioral and cognitive outcomes following traumatic brain injury in early childhood. J Pediatr Psychol 40, 391-397. Giza, C.C., Kolb, B., Harris, N.G., Asarnow, R.F., Prins, M.L., 2009. Hitting a
RI PT
moving target: Basic mechanisms of recovery from acquired developmental brain injury. Dev Neurorehabil 12, 255-268.
Giza, C.C., Prins, M.L., 2006. Is being plastic fantastic? Mechanisms of
SC
altered plasticity after developmental traumatic brain injury. Dev Neurosci 28, 364-379.
M AN U
Greco, T., Glenn, T.C., Hovda, D.A., Prins, M.L., 2016. Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J Cereb Blood Flow Metab 36, 1603-1613.
Gu, X., Wei, Z.Z., Espinera, A., Lee, J.H., Ji, X., Wei, L., Dix, T.A., Yu, S.P.,
TE D
2015. Pharmacologically induced hypothermia attenuates traumatic brain injury in neonatal rats. Exp Neurol 267, 135-142. Hanlon, L.A., Huh, J.W., Raghupathi, R., 2016. Minocycline Transiently
EP
Reduces Microglia/Macrophage Activation but Exacerbates Cognitive Deficits
AC C
Following Repetitive Traumatic Brain Injury in the Neonatal Rat. J Neuropathol Exp Neurol 75, 214-226. Harati, R., Villegier, A.S., Banks, W.A., Mabondzo, A., 2012. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of Pglycoprotein and breast cancer resistance protein expression and transport activity. J Neuroinflammation 9, 273. Hawkes, C.A., Gatherer, M., Sharp, M.M., Dorr, A., Yuen, H.M., Kalaria, R., Weller, R.O., Carare, R.O., 2013. Regional differences in the morphological
31
ACCEPTED MANUSCRIPT and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-beta from the mouse brain. Aging Cell 12, 224-236. Hawkes, C.A., Shaw, J.E., Brown, M., Sampson, A.P., McLaurin, J., Carare,
TgCRND8 mice. Neurodegener Dis 13, 17-23.
RI PT
R.O., 2014. MK886 reduces cerebral amyloid angiopathy severity in
Iadecola, C., 2004. Neurovascular regulation in the normal brain and in
SC
Alzheimer's disease. Nat Rev Neurosci 5, 347-360.
Jernigan, T.L., Baaré, W.F., Stiles, J., Madsen, K.S., 2011. Postnatal brain
Prog Brain Res 189, 77-92.
M AN U
development: structural imaging of dynamic neurodevelopmental processes.
Jiang, J.Y., Lyeth, B.G., Kapasi, M.Z., Jenkins, L.W., Povlishock, J.T., 1992. Moderate hypothermia reduces blood-brain barrier disruption following
TE D
traumatic brain injury in the rat. Acta Neuropathol 84, 495-500. Jodoin, J., Demeule, M., Fenart, L., Cecchelli, R., Farmer, S., Linton, K.J., Higgins, C.F., Beliveau, R., 2003. P-glycoprotein in blood-brain barrier
EP
endothelial cells: interaction and oligomerization with caveolins. J Neurochem
AC C
87, 1010-1023.
Jullienne, A., Obenaus, A., Ichkova, A., Savona-Baron, C., Pearce, W.J., Badaut, J., 2016. Chronic cerebrovascular dysfunction after traumatic brain injury. J Neurosci Res 94, 609-622. Jullienne, A., Roberts, J.M., Pop, V., Paul Murphy, M., Head, E., Bix, G.J., Badaut, J., 2014. Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation. J Cereb Blood Flow Metab.
32
ACCEPTED MANUSCRIPT Kamper, J.E., Pop, V., Fukuda, A.M., Ajao, D.O., Hartman, R.E., Badaut, J., 2013. Juvenile traumatic brain injury evolves into a chronic brain disorder: behavioral and histological changes over 6months. Exp Neurol 250, 8-19. Kasemsri, T., Armstead, W.M., 1997. Endothelin impairs ATP-sensitive K+
RI PT
channel function after brain injury. Am J Physiol 273, H2639-2647.
Keightley, M.L., Sinopoli, K.J., Davis, K.D., Mikulis, D.J., Wennberg, R., Tartaglia, M.C., Chen, J.K., Tator, C.H., 2014. Is there evidence for
SC
neurodegenerative change following traumatic brain injury in children and youth? A scoping review. Front Hum Neurosci 8, 139.
M AN U
Knowland, D., Arac, A., Sekiguchi, K.J., Hsu, M., Lutz, S.E., Perrino, J., Steinberg, G.K., Barres, B.A., Nimmerjahn, A., Agalliu, D., 2014. Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 82, 603-617.
TE D
Kochanek, P.M., Carney, N., Adelson, P.D., Ashwal, S., Bell, M.J., Bratton, S., Carson, S., Chesnut, R.M., Ghajar, J., Goldstein, B., Grant, G.A., Kissoon, N., Peterson, K., Selden, N.R., Tasker, R.C., Tong, K.A., Vavilala, M.S.,
EP
Wainwright, M.S., Warden, C.R., Surgery, A.A.o.P.-S.o.N., Surgeons,
AC C
A.A.o.N.S.C.o.N., Society, C.N., Care, E.S.o.P., Intensive, N., Society, N.C., Group, P.N.C.R., Medicine, S.o.C.C., UK, P.I.C.S., Care, S.f.N.i.A., Critical, Societies, W.F.o.P.I., Care, C., 2012. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. Pediatr Crit Care Med 13 Suppl 1, S1-82. Lang, D.A., Teasdale, G.M., Macpherson, P., Lawrence, A., 1994. Diffuse brain swelling after head injury: more often malignant in adults than children? J Neurosurg 80, 675-680.
33
ACCEPTED MANUSCRIPT Lebel, C., Walker, L., Leemans, A., Phillips, L., Beaulieu, C., 2008. Microstructural maturation of the human brain from childhood to adulthood. Neuroimage 40, 1044-1055. Leung, J., Kosinski, P.D., Croal, P.L., Kassner, A., 2016. Developmental
RI PT
trajectories of cerebrovascular reactivity in healthy children and young adults assessed with magnetic resonance imaging. J Physiol 594, 2681-2689.
Maa, T., Yeates, K.O., Moore-Clingenpeel, M., O'Brien, N.F., 2016. Age-
SC
related carbon dioxide reactivity in children after moderate and severe traumatic brain injury. J Neurosurg Pediatr 18, 73-78.
M AN U
Maas, A.I., Stocchetti, N., Bullock, R., 2008. Moderate and severe traumatic brain injury in adults. Lancet Neurol 7, 728-741.
Mannix, R., Berglass, J., Berkner, J., Moleus, P., Qiu, J., Jantzie, L.L., Meehan, W.P., Stanley, R.M., Robinson, S., 2014. Sex differences in the
TE D
effect of progesterone after controlled cortical impact in adolescent mice: a preliminary study. J Neurosurg 121, 1337-1341. Margulies, S., Anderson, G., Atif, F., Badaut, J., Clark, R., Empey, P.,
EP
Guseva, M., Hoane, M., Huh, J., Pauly, J., Raghupathi, R., Scheff, S., Stein,
AC C
D., Tang, H., Hicks, M., 2016. Combination Therapies for Traumatic Brain Injury: Retrospective Considerations. J Neurotrauma 33, 101-112. McCaffrey, G., Staatz, W.D., Quigley, C.A., Nametz, N., Seelbach, M.J., Campos, C.R., Brooks, T.A., Egleton, R.D., Davis, T.P., 2007. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem 103, 2540-2555. McCaffrey, G., Staatz, W.D., Sanchez-Covarrubias, L., Finch, J.D., Demarco, K., Laracuente, M.L., Ronaldson, P.T., Davis, T.P., 2012. P-glycoprotein
34
ACCEPTED MANUSCRIPT trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. J Neurochem 122, 962-975. McKee, A.C., Stein, T.D., Kiernan, P.T., Alvarez, V.E., 2015. The
364.
RI PT
neuropathology of chronic traumatic encephalopathy. Brain Pathol 25, 350-
Mhanna, M.J., Mallah, W.E., Verrees, M., Shah, R., Super, D.M., 2015. Outcome of children with severe traumatic brain injury who are treated with
SC
decompressive craniectomy. J Neurosurg Pediatr, 1-7.
Muramatsu, K., Fukuda, A., Togari, H., Wada, Y., Nishino, H., 1997.
M AN U
Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier. Stroke 28, 22812288; discussion 2288-2289.
Nagel, C., Diedler, J., Gerbig, I., Heimberg, E., Schuhmann, M.U., Hockel, K.,
TE D
2016. State of Cerebrovascular Autoregulation Correlates with Outcome in Severe Infant/Pediatric Traumatic Brain Injury. Acta Neurochir Suppl 122, 239-244.
EP
Obermeier, B., Daneman, R., Ransohoff, R.M., 2013. Development,
AC C
maintenance and disruption of the blood-brain barrier. Nat Med 19, 15841596.
Ommaya, A.K., Goldsmith, W., Thibault, L., 2002. Biomechanics and neuropathology of adult and paediatric head injury. Br J Neurosurg 16, 220242. Philip,
S.,
Udomphorn,
Y.,
Kirkham,
F.J.,
Vavilala,
M.S.,
2009.
Cerebrovascular pathophysiology in pediatric traumatic brain injury. J Trauma 67, S128-134.
35
ACCEPTED MANUSCRIPT Pierre, K., Pellerin, L., 2005. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94, 1-14. Pop, V., Badaut, J., 2011. A Neurovascular Perspective for Long-Term Changes After Brain Trauma. Transl Stroke Res 2, 533-545.
RI PT
Pop, V., Sorensen, D.W., Kamper, J.E., Ajao, D.O., Murphy, M.P., Head, E., Hartman, R.E., Badaut, J., 2013. Early brain injury alters the blood-brain barrier phenotype in parallel with beta-amyloid and cognitive changes in
SC
adulthood. J Cereb Blood Flow Metab 33, 205-214.
Prins, M.L., Giza, C.C., 2006. Induction of monocarboxylate transporter 2
M AN U
expression and ketone transport following traumatic brain injury in juvenile and adult rats. Dev Neurosci 28, 447-456.
Prins, M.L., Lee, S.M., Cheng, C.L., Becker, D.P., Hovda, D.A., 1996. Fluid percussion brain injury in the developing and adult rat: a comparative study of
TE D
mortality, morphology, intracranial pressure and mean arterial blood pressure. Brain Res Dev Brain Res 95, 272-282.
Quintard, H., Patet, C., Zerlauth, J.B., Suys, T., Bouzat, P., Pellerin, L., Meuli,
EP
R., Magistretti, P.J., Oddo, M., 2016. Improvement of Neuroenergetics by
AC C
Hypertonic Lactate Therapy in Patients with Traumatic Brain Injury Is Dependent on Baseline Cerebral Lactate/Pyruvate Ratio. J Neurotrauma 33, 681-687.
Raz, L., Knoefel, J., Bhaskar, K., 2016. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab 36, 172-186. Readnower, R.D., Chavko, M., Adeeb, S., Conroy, M.D., Pauly, J.R., McCarron, R.M., Sullivan, P.G., 2010. Increase in blood-brain barrier
36
ACCEPTED MANUSCRIPT permeability, oxidative stress, and activated microglia in a rat model of blastinduced traumatic brain injury. J Neurosci Res 88, 3530-3539. Robertson, C.L., Saraswati, M., 2015. Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury. J Bioenerg
RI PT
Biomembr 47, 43-51.
Robertson, P.L., Du Bois, M., Bowman, P.D., Goldstein, G.W., 1985. Angiogenesis in developing rat brain: an in vivo and in vitro study. Brain Res
SC
355, 219-223.
Rossi, J.L., Todd, T., Daniels, Z., Bazan, N.G., Belayev, L., 2015. Interferon-
M AN U
Stimulated Gene 15 Upregulation Precedes the Development of Blood-Brain Barrier Disruption and Cerebral Edema after Traumatic Brain Injury in Young Mice. J Neurotrauma 32, 1101-1108.
Roumeliotis, N., Dong, C., Pettersen, G., Crevier, L., Emeriaud, G., 2016.
Childs Nerv Syst.
TE D
Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective study.
Ryan, N.P., Catroppa, C., Cooper, J.M., Beare, R., Ditchfield, M., Coleman,
EP
L., Silk, T., Crossley, L., Rogers, K., Beauchamp, M.H., Yeates, K.O.,
AC C
Anderson, V.A., 2015. Relationships between acute imaging biomarkers and theory of mind impairment in post-acute pediatric traumatic brain injury: A prospective
analysis
using
susceptibility
weighted
imaging
(SWI).
Neuropsychologia 66, 32-38. Ryan, N.P., Catroppa, C., Godfrey, C., Noble-Haeusslein, L.J., Shultz, S.R., O'Brien, T.J., Anderson, V., Semple, B.D., 2016. Social dysfunction after pediatric traumatic brain injury: A translational perspective. Neurosci Biobehav Rev 64, 196-214.
37
ACCEPTED MANUSCRIPT Sahuquillo, J., Vilalta, A., 2007. Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury. Curr Pharm Des 13, 2310-2322. Salonia, R., Empey, P.E., Poloyac, S.M., Wisniewski, S.R., Klamerus, M.,
RI PT
Ozawa, H., Wagner, A.K., Ruppel, R., Bell, M.J., Feldman, K., Adelson, P.D., Clark, R.S., Kochanek, P.M., 2010. Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe
SC
traumatic brain injury. J Neurotrauma 27, 1819-1825.
Saunders, N.R., Liddelow, S.A., Dziegielewska, K.M., 2012. Barrier
M AN U
mechanisms in the developing brain. Front Pharmacol 3, 46.
Schneier, A.J., Shields, B.J., Hostetler, S.G., Xiang, H., Smith, G.A., 2006. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States. Pediatrics 118, 483-492.
TE D
Shlosberg, D., Benifla, M., Kaufer, D., Friedman, A., 2010. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6, 393-403.
EP
Stonestreet, B.S., Sadowska, G.B., McKnight, A.J., Patlak, C., Petersson,
AC C
K.H., 2000. Exogenous and endogenous corticosteroids modulate blood-brain barrier development in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 279, R468-477. Sysyn, G.D., Petersson, K.H., Patlak, C.S., Sadowska, G.B., Stonestreet, B.S., 2001. Effects of postnatal dexamethasone on blood-brain barrier permeability and brain water content in newborn lambs. Am J Physiol Regul Integr Comp Physiol 280, R547-553.
38
ACCEPTED MANUSCRIPT Taylor, Z.E., Spinrad, T.L., VanSchyndel, S.K., Eisenberg, N., Huynh, J., Sulik, M.J., Granger, D.A., 2013. Sociodemographic risk, parenting, and effortful control: relations to salivary alpha-amylase and cortisol in early childhood. Dev Psychobiol 55, 869-880.
RI PT
Thurman, D.J., 2016. The Epidemiology of Traumatic Brain Injury in Children and Youths: A Review of Research Since 1990. J Child Neurol 31, 20-27.
Toga, A.W., Thompson, P.M., Sowell, E.R., 2006. Mapping brain maturation.
SC
Trends Neurosci 29, 148-159.
Udomphorn, Y., Armstead, W.M., Vavilala, M.S., 2008. Cerebral blood flow
M AN U
and autoregulation after pediatric traumatic brain injury. Pediatr Neurol 38, 225-234.
Unterberg, A.W., Stover, J., Kress, B., Kiening, K.L., 2004. Edema and brain trauma. Neuroscience 129, 1019-1027.
TE D
Vavilala, M.S., Lee, L.A., Boddu, K., Visco, E., Newell, D.W., Zimmerman, J.J., Lam, A.M., 2004. Cerebral autoregulation in pediatric traumatic brain injury. Pediatr Crit Care Med 5, 257-263.
EP
Vavilala, M.S., Lee, L.A., Lam, A.M., 2003. The lower limit of cerebral
AC C
autoregulation in children during sevoflurane anesthesia. J Neurosurg Anesthesiol 15, 307-312. Vavilala, M.S., Muangman, S., Tontisirin, N., Fisk, D., Roscigno, C., Mitchell, P., Kirkness, C., Zimmerman, J.J., Chesnut, R., Lam, A.M., 2006. Impaired cerebral autoregulation and 6-month outcome in children with severe traumatic brain injury: preliminary findings. Dev Neurosci 28, 348-353. Vavilala, M.S., Tontisirin, N., Udomphorn, Y., Armstead, W., Zimmerman, J.J., Chesnut, R., Lam, A.M., 2008. Hemispheric differences in cerebral
39
ACCEPTED MANUSCRIPT autoregulation in children with moderate and severe traumatic brain injury. Neurocrit Care 9, 45-54. Wei, Z.Z., Lee, J.H., Zhang, Y., Zhu, Y.B., Deveau, T.C., Gu, X., Winter, M.M., Li, J., Wei, L., Yu, S.P., 2016. Intracranial Transplantation of HypoxiaiPSC-Derived
Neural
Progenitor
Cells
Alleviates
RI PT
Preconditioned
Neuropsychiatric Defects After Traumatic Brain Injury in Juvenile Rats. Cell Transplant 25, 797-809.
SC
Winkler, E.A., Bell, R.D., Zlokovic, B.V., 2010. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta
M AN U
receptor signaling. Mol Neurodegener 5, 32.
Winkler, E.A., Bell, R.D., Zlokovic, B.V., 2011. Central nervous system pericytes in health and disease. Nat Neurosci 14, 1398-1405. Zhang, B.F., Wang, J., Liu, Z.W., Zhao, Y.L., Li, D.D., Huang, T.Q., Gu, H.,
TE D
Song, J.N., 2015. Meta-analysis of the efficacy and safety of therapeutic hypothermia in children with acute traumatic brain injury. World Neurosurg 83, 567-573.
The
vascular
neural
network-a
new
paradigm
in
stroke
AC C
2012.
EP
Zhang, J.H., Badaut, J., Tang, J., Obenaus, A., Hartman, R., Pearce, W.J.,
pathophysiology. Nat Rev Neurol 8, 711-716.
40
ACCEPTED MANUSCRIPT Figure Legends
Figure 1: Summary time-line of pathophysiological cascades following juvenile TBI. Preclinical and clinical data agree on a consistent description of
RI PT
the course of secondary events within days and weeks after TBI (solid lines) compared to the control level in the time (dashed center line). Behavior (purple line), from motor dysfunctions to memory, is impaired within minutes
SC
of most pediatric TBI injuries and partial recovery occurs in the weeks and months following injury. Certain behavior repertoire exhibits continued
M AN U
impairment years later. Potential underlying mechanisms for acute and longterm behavioral impairment may be: decrease of the cerebral blood flow, autoregulation impairment, hypometabolism (red line); increased edema and brain swelling (brown line) during the first week; increase of BBB dysfunction
TE D
with BBB disruption as well as phenotype changes at long-term (Figure 2 and 3); associated with increased neuropathology accumulation of proteins such as Aβ (blue line and see Figure 3). Some of the changes after pediatric TBI
EP
are transient and return to normal, such as edema (brown line). Increase of
AC C
the BBB permeability (green line) returns to normal after a week, however long-term BBB modifications are observed (see Figure 2 and 3). All this evidence indicates increased neuropathology long time after injury, even for mild TBI. Since changes in the NVU after TBI are not transient, there is an opportunity to develop new drugs targeting the NVU that can be useful for treating this type of injuries both in the short- and long-term. (Adapted with permission from Pop and Badaut, 2011; TBI: traumatic brain injury; BBB: blood-brain barrier; IgG: immunoglobulin G; Aβ: beta-amyloid)
41
ACCEPTED MANUSCRIPT
Figure 2:
Longterm neurovascular phenotypic transformation in
pediatric TBI. (A, B) Tomato-lectin (t-lectin) histochemistry stained the cerebral blood vessels showing significant morphological changes in TBI
RI PT
animals (B) compared to naive animals (A) at 2 months post-injury. Capillary diameter is significantly decreased in TBI group (B) (modified with permission from Jullienne et al., 2014). (C, D) P-gp immunostaining is specific for
SC
endothelial cells (green) and not present in the astrocyte end-feet of GFAPpositive astrocytes in both naive and TBI (red) P-gp expression is significantly
M AN U
decreased in TBI (D) compared to the control group (C) (modified from Pop et al., 2013). (E, F) The perivascular protein fibronectin is almost not visible in adult naive animals (E) but it was observed (red) in TBI group (F) around cerebral blood vessels 2 months after the injury (modified with permission
TE D
from Jullienne et al., 2014).
Figure 3: Accumulation of rodent-Aβ deposition 2 months after pediatric
EP
TBI caused by decrease of the clearance system. (A, B) Rodent-Aβ
AC C
staining (A) is observed in several brain regions remote from the site of the impact (B, red arrowheads). Rodent-Aβ stains a cluster of several extracellular diffuse deposits (white arrows) and vascular labeling (white arrowheads) in the frontal cortex (bregma +2mm). The distribution of the presence of Aβ is observed around the cavity after the lesion (B, black arrowheads) and at distance in frontal and occipital in the contralateral side (red arrowheads). Scale bar A=100 µm. (Modified with permission from Pop et al., 2013) (C) A schematic representation of the changes in the neurovascular
42
ACCEPTED MANUSCRIPT unit (NVU) two months after TBI, which shows phenotypic alterations of NVU occurring in parallel with accumulation of extracellular proteins such as Aβ and behavioral dysfunction. We observed increase of the levels of claudin-5 (Pop et al., 2013), a protein composing the tight junctions and a decrease of
RI PT
P-gp, an efflux transporter proposed to contribute to the clearance of Aβ. In addition to the modifications of the BBB properties, the diameter of the capillaries is significantly decreased with possible consequences on the
SC
cerebral blood flow. The changes in the protein of the perivascular matrix fibronectin and perlecan/ domain V may also contribute to the decrease of the
M AN U
Aβ clearance. Collectively, these changes within the NVU may contribute to the decreased Aβ clearance observed after TBI and accelerate the neurodegenerative process (Schematic drawing modified and adapted with
AC C
EP
TE D
permission from Pop et al., 2013 and Jullienne et al., 2014).
43
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT